IGF-2 signal inhibiting peptides (University of California Davis)

N/A

Report date: 2025/03/20 14:55:09

Base Information

Drug NameIGF-2 signal inhibiting peptides (University of California Davis)
Drug Alias Nameinsulin-like growth hormone-2 inhibiting inhibiting peptides (University of California Davis)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin-like growth factor II receptor inhibitorsInsulin-like growth factor I receptor modulators
TargetsInsulin-like growth factor I receptorInsulin-like growth factor II receptor
Therapy Area/IndicationsInflammationFibrosisAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaThe University Of California Davis
Inactive CompaniesN/A
Active IndicationsInflammationFibrosisAutoimmune Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A